A King County Superior Court judge ordered Albertsons to pay $900 million on Nov. 5 in Washington’s opioid case, plus fees and costs, after finding its pharmacies filled red-flagged opioid prescriptions more than 6.5 million times without documenting efforts to confirm they were legitimate. Washington Attorney General Nick Brown’s office announced the $900 million judgment, which covers Albertsons, Safeway and Haggen pharmacies in the state. The release does not say whether the company will appeal.
The case turned on a plain question: what a pharmacy must do when a prescription looks wrong. Albertsons owns more than 200 pharmacies in Washington under those three banners, and the state argued that too many of those prescriptions were filled anyway.
Stay ahead of government payment news: Miss an enrollment or claim deadline and the money can be gone. Join the Retirement Money Brief and we’ll send you our 2026 Government Check Reality Tracker as a welcome gift.
Get the Brief + the check tracker →
We may earn a commission from links on this page.
What did the court say Albertsons did wrong?
The attorney general’s office says Albertsons dispensed more than 641 million opioid pills into Washington between 2006 and 2022, most of them with red flags that went unresolved. The state also pointed to a Safeway employee who stole more than 70,000 pills in North Bend over two years, and to staffing shortages that pharmacists called “impossible” to manage while reviewing prescriptions.
Judge Janet Helson heard the case without a jury, according to Courthouse News, which covered the opening of the trial. The attorney general’s office had sued several chain pharmacies in 2022. The others settled early or declared bankruptcy, leaving Albertsons as the only defendant at trial.
The period at issue stretches 16 years, from 2006 through 2022, so the judgment reaches practices that predate the lawsuit the attorney general’s office filed in 2022. The release says the pharmacies filled the flagged prescriptions more than 6.5 million times, which is the figure the state tied to its claim that Albertsons failed to document efforts to confirm a legitimate medical purpose.
What did the state argue at trial?
Coverage of the trial’s opening says the state alleged Albertsons repeatedly failed to resolve “red flags of diversion” before dispensing opioids. The state also alleged the company failed to report tens of thousands of suspicious orders to the Drug Enforcement Administration, that company policies discouraged pharmacists from identifying problem prescribers, and that stores could not share risk information with each other.
The state also said Albertsons sent opioids to its own stores through self-distribution for a period, that some stores could not turn away prescriptions from known “pill mill” prescribers, that controlled-substance inventory was not closely tracked for theft, and that policies incentivized prescription volume while stores were understaffed. The trial was expected to run into September with dozens of expert witnesses.
Attorney Kelsey Endres, arguing for the state, told the court that over the last three years alone, more than 7,400 people had died of opioid overdoses in Washington. State attorney Dan Albertsone told the court that pharmacies “are not simply vending machines.” Brown said in the release, “When giant corporations put profits above safety, they will be held accountable.”
What does Albertsons say?
Albertsons’ lawyer Enu Mainigi told the court during the trial, “Albertsons does not drive demand for opioids. Nothing happens without a doctor’s prescription.” A company spokesperson said Albertsons has taken meaningful steps to address opioid claims through a national settlement framework, which the company says is not an admission of wrongdoing. The spokesperson said Washington did not take part in that framework, so the company was addressing the state’s case through the courts.
Those statements were made while the trial was under way, and the state’s release gives no word yet on how the company will respond to the judgment.
Where does the $900 million go?
The attorney general says the judgment is meant to address the consequences of the violations and will “provide desperately needed resources to support treatment and prevent future crises.” The release says the money will expand treatment and prevention resources statewide. It does not give a breakdown by program or by county, and it does not state the amount of the fees and costs that come on top of the $900 million.
The office says that since the opioid crisis began it has recovered $2.17 billion for state and local governments. Money from a judgment goes to the state, not to individual customers, and the release does not describe any payments to people who filled prescriptions at the stores.
Does this change anything at the pharmacy counter?
Nothing in the state’s release changes what a customer pays or how a prescription is filled. The practical effect for most shoppers is indirect: the ruling puts Washington’s pharmacy chains on notice that unresolved red flags are a legal risk, and the attorney general says the money is meant for treatment and prevention.
For people who fill several prescriptions each month, the more direct money question is the one at the register, which depends on their plan, their deductible and, for Medicare enrollees, the annual out-of-pocket drug cap.
With pharmacy costs on your mind, where else is a prescription budget leaking?
The Albertsons judgment is about how a chain handled prescriptions, not about what customers owe at the counter. A household still pays for its own medicines every month, and Medicare costs, taxes and housing bills tend to move faster than court cases do.
The Keep-It Starter Bundle is nine short guides in one download, one for each place retirees quietly lose money. It includes how to cut Medicare costs by appealing the income surcharge and using the drug cap, and how to cut the tax bill with the senior deduction, RMDs, QCDs and the Roth window.
Get the nine guides, including how to cut Medicare costs and use the drug cap →
This article was produced with AI assistance and edited for accuracy against the sources linked above.
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
